CAPER as a therapeutic target for triple negative breast cancer

Breast cancers (BCas) that lack expression of the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) are referred to as triple negative breast cancers (TNBCs) and have the poorest clinical outcome. Once these aggressive tumors progress to distant...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncotarget
Main Authors: Campbell, Mallory C., Pontiggia, Laura, Russell, Ashley Y., Schwarting, Roland, Camacho, Jeanette, Jasmin, Jean-Francois, Mercier, Isabelle
Formato: Artigo
Idioma:Inglês
Publicado em: Impact Journals LLC 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6084388/
https://ncbi.nlm.nih.gov/pubmed/30100993
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25719
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados